Acquisition by Dwyer Donald of 500 shares of Vivani Medical at 1.13 subject to Rule 16b-3
| VANI Stock | USD 1.34 0.01 0.75% |
Under 51% of Vivani Medical's investor base is interested to short. The analysis of the overall investor sentiment regarding Vivani Medical suggests that many traders are impartial. Vivani Medical's investing sentiment shows overall attitude of investors towards Vivani Medical.
Vivani |
Filed transaction by Vivani Medical Officer: Chief Business Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at investing.com
 |
Vivani Medical Fundamental Analysis
We analyze Vivani Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vivani Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vivani Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Vivani Medical is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Vivani Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vivani Medical stock to make a market-neutral strategy. Peer analysis of Vivani Medical could also be used in its relative valuation, which is a method of valuing Vivani Medical by comparing valuation metrics with similar companies.
Peers
Vivani Medical Related Equities
| ANTX | AN2 Therapeutics | 8.94 | ||||
| HCWB | HCW Biologics | 8.45 | ||||
| PHVS | Pharvaris | 5.94 | ||||
| TRDA | Entrada Therapeutics | 4.16 | ||||
| TYRA | Tyra Biosciences | 3.06 | ||||
| RLYB | Rallybio Corp | 3.03 | ||||
| PMVP | Pmv Pharmaceuticals | 2.55 | ||||
| PEPG | PepGen | 2.08 | ||||
| ELYM | Eliem Therapeutics | 2.60 | ||||
| ANEB | Anebulo Pharmaceuticals | 2.67 |
Complementary Tools for Vivani Stock analysis
When running Vivani Medical's price analysis, check to measure Vivani Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivani Medical is operating at the current time. Most of Vivani Medical's value examination focuses on studying past and present price action to predict the probability of Vivani Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivani Medical's price. Additionally, you may evaluate how the addition of Vivani Medical to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |